Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:person
|
| gptkbp:almaMater |
gptkb:Harvard_Business_School
gptkb:University_of_Oxford |
| gptkbp:appointedBy |
Chair of UK Vaccine Taskforce in May 2020
|
| gptkbp:birthYear |
1965
|
| gptkbp:child |
3 children
|
| gptkbp:education |
gptkb:Harvard_Business_School
gptkb:University_of_Oxford |
| gptkbp:employer |
gptkb:SV_Health_Investors
|
| gptkbp:field |
gptkb:biotechnology
|
| gptkbp:gender |
female
|
| gptkbp:honor |
gptkb:Order_of_the_British_Empire
|
| gptkbp:honorYear |
2021
|
| https://www.w3.org/2000/01/rdf-schema#label |
Kate Bingham
|
| gptkbp:nationality |
British
|
| gptkbp:notableFor |
Chair of UK Vaccine Taskforce
|
| gptkbp:occupation |
gptkb:business_executive
biotechnology venture capitalist |
| gptkbp:parent |
gptkb:Thomas_Bingham,_Baron_Bingham_of_Cornhill
|
| gptkbp:position |
managing partner at SV Health Investors
|
| gptkbp:spouse |
gptkb:Jesse_Norman
|
| gptkbp:bfsParent |
gptkb:UK_Government_Vaccine_Taskforce
|
| gptkbp:bfsLayer |
6
|